P3 Health Partners
PIII
17 hedge funds and large institutions have $750K invested in P3 Health Partners in 2026 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.
167% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 3
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
31% more funds holding
Funds holding: 13 → 17 (+4)
1.55% less ownership
Funds ownership: 8.94% → 7.39% (-1.5%)
27% less capital invested
Capital invested by funds: $1.03M → $750K (-$277K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DT
Diversified Trust
Memphis,
Tennessee
|
+$53.5K |
| 2 |
NMC
Nine Masts Capital
Central,
Hong Kong
|
+$47.3K |
| 3 |
HF
HRT Financial
New York
|
+$39.7K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$35.2K |
| 5 |
Lido Advisors
Los Angeles,
California
|
+$28.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$480K |
| 2 |
Corient Private Wealth
Miami,
Florida
|
-$57.5K |
| 3 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$4.79K |
| 4 |
TFA
Trinity Financial Advisors
Columbus,
Ohio
|
-$4.21K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.75K |
PIII Hedge Fund Activity: Q1 2026 in Review
17 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in P3 Health Partners (PIII) for Q1 2026, worth a combined $750K — down 27% from $1.03M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new PIII positions and 3 closed out — a net gain of 5 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Diversified Trust, opening a new position worth an estimated $53.5K. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $480K sold.
- 17 institutional investors held P3 Health Partners (PIII) as of Q1 2026, up from 13 in Q4 2025.
- Funds reported $750K of P3 Health Partners stock for Q1 2026, down 27% quarter-over-quarter.
- 8 funds opened new P3 Health Partners positions in Q1 2026 and 3 closed out, a net change of +5 holders.
- The largest P3 Health Partners buyer in Q1 2026 was Diversified Trust, an estimated $53.5K added.
- The largest P3 Health Partners seller in Q1 2026 was Alyeska Investment Group, an estimated $480K sold.
Based on aggregated 13F filings for Q1 2026.